Skip to content

Bausch + Lomb BLCO Free cash flow margin

Free cash flow margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
13.5%+4.3pp
Glaukos logo
GlaukosGKOS
-13.2%-3.9pp
AbbVie logo
AbbVieABBV
31.8%+5.0pp
Warby Parker logo
Warby ParkerWRBY
4.5%-0.8pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
27.6%+5.5pp

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Calculated from Bausch + Lomb’s reported figures.

Based on trailing twelve months.

The official record: Bausch + Lomb’s 10-Q, filed July 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's free cash flow margin?
Bausch + Lomb (BLCO) reported free cash flow margin of -3.4% in Q2 2025.
How has Bausch + Lomb's free cash flow margin changed year-over-year?
Bausch + Lomb's free cash flow margin increased by 0.2% year-over-year, from -3.4% to -3.4%.
What is the long-term trend for Bausch + Lomb's free cash flow margin?
Over 3 years (2020 to 2024), Bausch + Lomb's free cash flow margin has grown at a -46.1% compound annual growth rate (CAGR), from 7.9% to -1.2%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.